Acute kidney injury in critically ill infants: The role of urine Neutrophil Gelatinase-Associated Lipocalin (NGAL)

Michele Mussap, Roberta Degrandi, Marco Fravega, Vassilios Fanos

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Acute kidney injury (AKI) has emerged as an important health problem in the intensive care units, especially among infants delivered prematurely. Recent efforts to define and characterize AKI have led to studies of early AKI detection and will ultimately contribute to improvements in AKI outcomes. The discovery of biomarkers for AKI that might enable early recognition and clinical intervention to limit renal injury is therefore of intense contemporary interest. Neutrophil gelatinase-associated lipocalin (NGAL) is the most promising among all emerging markers for AKI; specifically, urine NGAL (uNGAL) predicts renal failure much earlier than serum creatinine. The recent availability of an automated immunoassay for measuring uNGAL in the clinical practice permits to introduce the test in emergency, having a turn around time (TAT) closely comparable with that of serum creatinine. On the basis of data reported in the literature, it is reasonable to forecast an increasing clinical use of uNGAL capable to change our approach to the diagnosis and leading to better preventative and therapeutic interventions which will improve outcomes of critically ill infants with acute kidney disease.

Original languageEnglish
Pages (from-to)70-72
Number of pages3
JournalJournal of Maternal-Fetal and Neonatal Medicine
Volume23
Issue numberSUPPL. 3
DOIs
Publication statusPublished - Oct 2010

Fingerprint

Acute Kidney Injury
Critical Illness
Urine
Creatinine
Kidney Diseases
Acute Disease
Serum
Immunoassay
Renal Insufficiency
Intensive Care Units
Lipocalin-2
Emergencies
Biomarkers
Kidney
Health
Wounds and Injuries

Keywords

  • Acute Kidney Injury (AKI)
  • Neutrophil Gelatinase-Associated Lipocalin (NGAL)
  • newborn

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynaecology
  • Medicine(all)

Cite this

Acute kidney injury in critically ill infants : The role of urine Neutrophil Gelatinase-Associated Lipocalin (NGAL). / Mussap, Michele; Degrandi, Roberta; Fravega, Marco; Fanos, Vassilios.

In: Journal of Maternal-Fetal and Neonatal Medicine, Vol. 23, No. SUPPL. 3, 10.2010, p. 70-72.

Research output: Contribution to journalArticle

Mussap, Michele ; Degrandi, Roberta ; Fravega, Marco ; Fanos, Vassilios. / Acute kidney injury in critically ill infants : The role of urine Neutrophil Gelatinase-Associated Lipocalin (NGAL). In: Journal of Maternal-Fetal and Neonatal Medicine. 2010 ; Vol. 23, No. SUPPL. 3. pp. 70-72.
@article{b6e4e06fb8764d85a8ebb80017c9ca2b,
title = "Acute kidney injury in critically ill infants: The role of urine Neutrophil Gelatinase-Associated Lipocalin (NGAL)",
abstract = "Acute kidney injury (AKI) has emerged as an important health problem in the intensive care units, especially among infants delivered prematurely. Recent efforts to define and characterize AKI have led to studies of early AKI detection and will ultimately contribute to improvements in AKI outcomes. The discovery of biomarkers for AKI that might enable early recognition and clinical intervention to limit renal injury is therefore of intense contemporary interest. Neutrophil gelatinase-associated lipocalin (NGAL) is the most promising among all emerging markers for AKI; specifically, urine NGAL (uNGAL) predicts renal failure much earlier than serum creatinine. The recent availability of an automated immunoassay for measuring uNGAL in the clinical practice permits to introduce the test in emergency, having a turn around time (TAT) closely comparable with that of serum creatinine. On the basis of data reported in the literature, it is reasonable to forecast an increasing clinical use of uNGAL capable to change our approach to the diagnosis and leading to better preventative and therapeutic interventions which will improve outcomes of critically ill infants with acute kidney disease.",
keywords = "Acute Kidney Injury (AKI), Neutrophil Gelatinase-Associated Lipocalin (NGAL), newborn",
author = "Michele Mussap and Roberta Degrandi and Marco Fravega and Vassilios Fanos",
year = "2010",
month = "10",
doi = "10.3109/14767058.2010.508217",
language = "English",
volume = "23",
pages = "70--72",
journal = "Journal of Maternal-Fetal and Neonatal Medicine",
issn = "1476-7058",
publisher = "Informa Healthcare",
number = "SUPPL. 3",

}

TY - JOUR

T1 - Acute kidney injury in critically ill infants

T2 - The role of urine Neutrophil Gelatinase-Associated Lipocalin (NGAL)

AU - Mussap, Michele

AU - Degrandi, Roberta

AU - Fravega, Marco

AU - Fanos, Vassilios

PY - 2010/10

Y1 - 2010/10

N2 - Acute kidney injury (AKI) has emerged as an important health problem in the intensive care units, especially among infants delivered prematurely. Recent efforts to define and characterize AKI have led to studies of early AKI detection and will ultimately contribute to improvements in AKI outcomes. The discovery of biomarkers for AKI that might enable early recognition and clinical intervention to limit renal injury is therefore of intense contemporary interest. Neutrophil gelatinase-associated lipocalin (NGAL) is the most promising among all emerging markers for AKI; specifically, urine NGAL (uNGAL) predicts renal failure much earlier than serum creatinine. The recent availability of an automated immunoassay for measuring uNGAL in the clinical practice permits to introduce the test in emergency, having a turn around time (TAT) closely comparable with that of serum creatinine. On the basis of data reported in the literature, it is reasonable to forecast an increasing clinical use of uNGAL capable to change our approach to the diagnosis and leading to better preventative and therapeutic interventions which will improve outcomes of critically ill infants with acute kidney disease.

AB - Acute kidney injury (AKI) has emerged as an important health problem in the intensive care units, especially among infants delivered prematurely. Recent efforts to define and characterize AKI have led to studies of early AKI detection and will ultimately contribute to improvements in AKI outcomes. The discovery of biomarkers for AKI that might enable early recognition and clinical intervention to limit renal injury is therefore of intense contemporary interest. Neutrophil gelatinase-associated lipocalin (NGAL) is the most promising among all emerging markers for AKI; specifically, urine NGAL (uNGAL) predicts renal failure much earlier than serum creatinine. The recent availability of an automated immunoassay for measuring uNGAL in the clinical practice permits to introduce the test in emergency, having a turn around time (TAT) closely comparable with that of serum creatinine. On the basis of data reported in the literature, it is reasonable to forecast an increasing clinical use of uNGAL capable to change our approach to the diagnosis and leading to better preventative and therapeutic interventions which will improve outcomes of critically ill infants with acute kidney disease.

KW - Acute Kidney Injury (AKI)

KW - Neutrophil Gelatinase-Associated Lipocalin (NGAL)

KW - newborn

UR - http://www.scopus.com/inward/record.url?scp=77957930887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957930887&partnerID=8YFLogxK

U2 - 10.3109/14767058.2010.508217

DO - 10.3109/14767058.2010.508217

M3 - Article

C2 - 20807163

AN - SCOPUS:77957930887

VL - 23

SP - 70

EP - 72

JO - Journal of Maternal-Fetal and Neonatal Medicine

JF - Journal of Maternal-Fetal and Neonatal Medicine

SN - 1476-7058

IS - SUPPL. 3

ER -